33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ... 33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
• 17% recurred with recurrence rates equal in both pure LCIS and LCIS+DCIS cases. • All recurrences were IPSILATERAL. • 50% of recurrences invasive carcinomas. • Recurrence related to extent and cell type type. • Recurrence Rate Among LCIS Types: (10 lobules LCIS + large nuclei) = 41% • I believe, CIS having mixed ductal & lobular features, should be (at least in part) called DCIS - this encourages complete excision. • YET, I mention the concomitant LCIS pattern to emphasize somewhat greater risk of bilateral carcinoma (e (e.g., g “mixed mixed ductal & lobular CIS”) CIS ). • This encourages adequate follow-up studies of the contra-lateral breast. WHO 2003 “The current recommended management for lobular neoplasia is life long followup with or without tamoxifen rx. Re- excision i i should h ld bbe considered id d iin cases of massive acinar distention, and when pleomorphic, signet ring, or necrotic variants are identified at or close to the margin.” 10/8/2011 20
Examples of E-cadherin staining in Breast Carcinomas - Classic and Otherwise - CASE A Classic ILC & LCIS 10/8/2011 21
- Page 1 and 2: 33 Special Types of Invasive Breast
- Page 3 and 4: Special Types of Invasive Breast Ca
- Page 5 and 6: INVASIVE BREAST CARCINOMAS CONSIDER
- Page 7 and 8: ER Neg. PR Neg. HER2 Neg. CK 5/6 Po
- Page 9 and 10: Triple-negative Breast Carcinomas
- Page 11 and 12: E-cadherin E-cadherin EGFR ++ ER ne
- Page 13 and 14: ER/PR Positive HER2 Negative INVASI
- Page 15 and 16: Tubulolobular Signet-ring Histiocyt
- Page 17 and 18: Illustrative Example: 61 y/o female
- Page 19 and 20: E-Cadherin ER PR 10/8/2011 17
- Page 21: LCIS vs DCIS • Patients with lobu
- Page 25 and 26: Classic Low-grade DCIS - E-cadherin
- Page 27 and 28: E-cadherin IHC CASE D 10/8/2011 25
- Page 29 and 30: E-cadherin IHC CASE E 10/8/2011 27
- Page 31 and 32: Literature Summary: Correlation of
- Page 33 and 34: 10/8/2011 31
- Page 35 and 36: CD10 SMA MIB-1 10/8/2011 33
- Page 37 and 38: Carter et al. Cancer 1977 & 1983
- Page 39 and 40: Differential Diagnosis: 1. Invasive
- Page 41 and 42: 10/8/2011 39
- Page 43 and 44: SYNAPTOPHYSIN SMA 10/8/2011 41
- Page 45 and 46: Nassar et al. (AJSP 2006;30:501-7.)
- Page 47 and 48: Special Types of Invasive Breast Ca
- Page 49 and 50: Tubular carcinoma • It has been d
- Page 51 and 52: Tubular carcinoma Histopathology
- Page 53 and 54: Flat Epithelial Atypia When should
- Page 55 and 56: Microglandular adenosis + reticulin
- Page 57 and 58: mitosis ductal ductal, NST tubular
- Page 59 and 60: Treatment • Breast conservation t
- Page 61 and 62: Cribriform carcinoma Histopathology
- Page 63 and 64: Cribriform carcinoma Prognosis •
- Page 65 and 66: Cribriform Carcinoma Pearls of Path
- Page 67 and 68: Clinicopathological features Mucino
- Page 69 and 70: Case 4 Mucinous carcinoma Mixed muc
- Page 71 and 72: Treatment • Breast conservation a
• 17% recurred with recurrence rates equal<br />
in both pure LCIS and LCIS+DCIS cases.<br />
• All recurrences were IPSILATERAL.<br />
• 50% <strong>of</strong> recurrences invasive carcinomas.<br />
• Recurrence related to extent and cell type type.<br />
• Recurrence Rate Among LCIS <strong>Types</strong>:<br />
(10 lobules LCIS + large nuclei) = 41%<br />
• I believe, CIS having mixed ductal & lobular<br />
features, should be (at least in part) called DCIS -<br />
this encourages complete excision.<br />
• YET, I mention the concomitant LCIS pattern to<br />
emphasize somewhat greater risk <strong>of</strong> bilateral<br />
carcinoma (e (e.g., g “mixed mixed ductal & lobular CIS”) CIS ).<br />
• This encourages adequate follow-up studies <strong>of</strong><br />
the contra-lateral breast.<br />
WHO 2003<br />
“The current recommended management<br />
for lobular neoplasia is life long followup<br />
with or without tamoxifen rx. Re-<br />
excision i i should h ld bbe considered id d iin<br />
cases<br />
<strong>of</strong> massive acinar distention, and when<br />
pleomorphic, signet ring, or necrotic<br />
variants are identified at or close to the<br />
margin.”<br />
10/8/2011<br />
20